NO154882C - Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin. - Google Patents

Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.

Info

Publication number
NO154882C
NO154882C NO810351A NO810351A NO154882C NO 154882 C NO154882 C NO 154882C NO 810351 A NO810351 A NO 810351A NO 810351 A NO810351 A NO 810351A NO 154882 C NO154882 C NO 154882C
Authority
NO
Norway
Prior art keywords
benzodioxanyl
imidazoline
preparing
procedure
Prior art date
Application number
NO810351A
Other languages
English (en)
Norwegian (no)
Other versions
NO154882B (no
NO810351L (no
Inventor
Christopher Bourne Chapleo
Peter Leslie Myers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NO810351L publication Critical patent/NO810351L/no
Publication of NO154882B publication Critical patent/NO154882B/no
Publication of NO154882C publication Critical patent/NO154882C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO810351A 1980-02-04 1981-02-02 Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin. NO154882C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04

Publications (3)

Publication Number Publication Date
NO810351L NO810351L (no) 1981-08-05
NO154882B NO154882B (no) 1986-09-29
NO154882C true NO154882C (no) 1987-01-07

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810351A NO154882C (no) 1980-02-04 1981-02-02 Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.

Country Status (26)

Country Link
US (1) US4818764A (da)
EP (1) EP0033655B1 (da)
JP (1) JPS56122378A (da)
AR (1) AR225794A1 (da)
AT (1) ATE7228T1 (da)
AU (1) AU535320B2 (da)
CA (1) CA1156241A (da)
CS (1) CS254956B2 (da)
DD (1) DD155991A5 (da)
DE (1) DE3163256D1 (da)
DK (1) DK160092C (da)
ES (1) ES8202553A1 (da)
FI (1) FI67543C (da)
GB (1) GB2068376B (da)
GR (1) GR73853B (da)
HU (1) HU187295B (da)
IE (1) IE51736B1 (da)
IL (1) IL62039A (da)
NO (1) NO154882C (da)
NZ (1) NZ196162A (da)
PH (1) PH16249A (da)
PL (1) PL128368B1 (da)
PT (1) PT72435B (da)
SU (1) SU1128837A3 (da)
ZA (1) ZA81666B (da)
ZW (1) ZW2381A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
ATE23337T1 (de) * 1982-12-23 1986-11-15 Ici America Inc Chromanverbindungen.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
AU2001243297A1 (en) * 2000-02-29 2001-09-12 Merck Frosst Canada And Co. Method for treating or preventing depression
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
WO2023159145A1 (en) * 2022-02-16 2023-08-24 Terran Biosciences, Inc. Deuterated idazoxan and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
JPS5276346A (en) * 1975-12-22 1977-06-27 Sumitomo Bakelite Co Ltd Epoxy resin adhesive composition
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
PL128368B1 (en) 1984-01-31
EP0033655A2 (en) 1981-08-12
DK45081A (da) 1981-08-05
DE3163256D1 (en) 1984-05-30
GR73853B (da) 1984-05-07
ATE7228T1 (de) 1984-05-15
SU1128837A3 (ru) 1984-12-07
GB2068376A (en) 1981-08-12
DK160092C (da) 1991-06-24
NO154882B (no) 1986-09-29
PT72435B (pt) 1982-01-29
ZW2381A1 (en) 1981-06-24
JPS56122378A (en) 1981-09-25
US4818764A (en) 1989-04-04
HU187295B (en) 1985-12-28
AU535320B2 (en) 1984-03-15
ES499034A0 (es) 1982-02-01
CA1156241A (en) 1983-11-01
IE51736B1 (en) 1987-03-18
NZ196162A (en) 1983-06-17
AR225794A1 (es) 1982-04-30
DD155991A5 (de) 1982-07-21
DK160092B (da) 1991-01-28
ZA81666B (en) 1982-04-28
ES8202553A1 (es) 1982-02-01
CS73881A2 (en) 1987-07-16
IE810199L (en) 1981-08-04
CS254956B2 (en) 1988-02-15
IL62039A (en) 1985-01-31
FI67543C (fi) 1985-04-10
IL62039A0 (en) 1981-03-31
FI67543B (fi) 1984-12-31
AU6675881A (en) 1981-08-13
EP0033655A3 (en) 1981-11-25
EP0033655B1 (en) 1984-04-25
PL229488A1 (da) 1981-10-16
GB2068376B (en) 1983-06-22
NO810351L (no) 1981-08-05
PH16249A (en) 1983-08-16
JPH0231077B2 (da) 1990-07-11
PT72435A (en) 1981-03-01
FI810288L (fi) 1981-08-05

Similar Documents

Publication Publication Date Title
ES520638A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES507493A0 (es) Procedimiento de preparar compuestos benzoheterociclicos.
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
NO823798L (no) Fremgangsmaate ved fremstilling av polymerer.
NO154882C (no) Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
ES507545A0 (es) Procedimiento de preparar compuestos carbostirilicos.
NO802384L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-diarylthiofener
NO154165C (no) Fremgangsmaate ved fremstilling av 2,3,5-triklorpyridin.
DK469379A (da) Fremgangsmaade til fremstilling af 1-hydroxylerede 5,6-vitamind-forbindelser
NO152894C (no) Fremgangsmaate ved fremstilling av ureapellets.
NO822410L (no) Fremgangsmaate ved fremstilling av benzothiazolsulfonamid-derivater.
DK400381A (da) Fremgansmaade til fremstilling af penicillanoyloxymethyl-penicillanoyloxymethyl-penicillanat-1,1,1!,1!-tetraoxid
IT7926898A0 (it) Procedimento per preparare 1,2,3-tiadiazol-5-il-uree.
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
DK370781A (da) Fremgangsmaade til fremstilling af 3,4-bis-phenyl-1,2,4-triazoler
DK40482A (da) Fremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolinderivater
RO84099A (ro) Procedeu pentru obtinerea 1,2,5-o0adiazol-2-o0izilor
IT7924830A0 (it) Procedimento per preparare isopropenil-fenolo.
DK146067C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-phenoxypropoxypyrimidiner
DK217480A (da) Fremgangsmaade til fremstilling af 5-mercapto1,2,3-triazoler
NO812143L (no) Fremgangsmaate ved fremstilling av 6-hydrazon-pyrido(2,1-b)-kinazolin-11-oner
NO830046L (no) Fremgangsmaate for fremstilling av 6-aminoalkylpenicillansyre-1,1-dioksyder.
DK294981A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol.
ES502465A0 (es) Procedimiento de preparar nuevas triazoloquinoxalin-1,4-dio-nas antialergicas